142
Participants
Start Date
August 2, 2018
Primary Completion Date
August 22, 2022
Study Completion Date
August 24, 2022
Nivolumab
Specified dose on specified days
BCG
Specified dose on specified days
BMS-986205
Specified dose on specified days
Local Institution - 0089, Ciudad Autonoma Buenos Aires
Local Institution - 0068, Capital Federal
Local Institution - 0146, Camperdown
Local Institution - 0148, St Leonards
Instituto Oncologico De Cordoba, Córdoba
Local Institution - 0137, Mendoza
Local Institution, Viedma
Local Institution - 0051, New York
Local Institution - 0036, Bala-Cynwyd
IRCCS Istituto Nazionale Tumori Milano, Milan
Local Institution - 0001, Baltimore
Local Institution, Madrid
Local Institution - 0033, Málaga
Local Institution - 0049, Charleston
Local Institution - 0002, Myrtle Beach
Local Institution - 0056, Hapeville
Local Institution - 0031, Bordeaux
Local Institution - 0125, Tampa
Local Institution - 0057, Chattanooga
Local Institution - 0139, Santander
Local Institution - 0058, Columbus
Local Institution - 0136, Valencia
Local Institution - 0077, Ann Arbor
Local Institution - 0028, Angers
Local Institution - 0032, Minneapolis
Azienda Ospedaliera Universitaria Pisana, Pisa
Local Institution - 0088, Lille
Local Institution - 0023, New Lenox
Local Institution - 0091, Strasbourg
Wichita Urology Group, Wichita
Local Institution - 0040, Omaha
Urology Clinics Of North Texas, Pa, Dallas
Local Institution - 0048, Houston
Local Institution - 0140, Houston
Urology San Antonio Research, Pa, San Antonio
Local Institution - 0047, Lubbock
Instituto Nazionale Tumori Fondazione G. Pascale, Napoli
Local Institution, Itacorubi, Florianopolis
Local Institution - 0044, Los Angeles
Local Institution - 0027, Suresnes
Local Institution - 0081, Riverside
Local Institution - 0087, San Francisco
Local Institution - 0141, Seattle
Local Institution - 0128, Beijing
Local Institution - 0131, Beijing
Local Institution - 0116, Beijing
Local Institution - 0099, Beijing
Local Institution - 0054, Saint Petersburg
Local Institution - 0153, Saint Petersburg
Local Institution - 0098, Shanghai
Local Institution - 0094, Shanghai
Local Institution - 0097, Shanghai
Local Institution - 0102, Nanjing
Local Institution - 0112, Jinan
Local Institution - 0111, Yantai
Local Institution - 0062, Tuxtla Gutiérrez
Local Institution - 0133, Tianjin
Local Institution - 0126, Hangzhou
Local Institution - 0109, Nanchang
Local Institution - 0108, Fuzhou
Local Institution - 0129, Chongqing
Local Institution - 0117, Guangzhou
Local Institution - 0120, Chengdu
Local Institution - 0070, Omsk
Local Institution - 0154, Santiago
Local Institution - 0151, Curitiba
Local Institution - 0144, New Brunswick
Deleware Valley Urology, LLC, Voorhees Township
Local Institution - 0065, Capital Federal
Local Institution - 0072, Fortaleza
Local Institution - 0073, Porto Alegre
Local Institution - 0078, Jaú
Local Institution - 0150, Rio de Janeiro
Local Institution - 0074, São Paulo
Local Institution - 0143, North York
Local Institution - 0086, Toronto
Local Institution - 0084, Toronto
Local Institution - 0046, Québec
Local Institution - 0069, Santiago
Local Institution - 0093, Hong Kong
Local Institution - 0055, Mexico City
Local Institution - 0004, Amsterdam
Local Institution - 0003, Nijmegen
Local Institution - 0005, Utrecht
Local Institution, Chelmsford
Local Institution, London
Local Institution - 0013, Southampton
Local Institution - 0015, Lancaster
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY